Herein, we demonstrated that inhibition of COX-2, mPGES-1 and CYP4A by ISL decreased FGF-2, TGF-β and VEGF production, and blocked glioma angiogenesis. This evidence concerns the gene TGFB1 and central nervous system cancer.